REFERENCES
1. World Health Organization. Management of birth defects and haemoglobin disorders. Report of a joint who-march of dimes meeting. Geneva, Switzerland, 17-19 May 2006. Available from: https://iris.who.int/bitstream/handle/10665/43587/9789241594929_eng.pdf?sequence=1 [Last accessed on 27 Feb 2024].
2. Malherbe HL, Modell B, Blencowe H, Strong KL, Aldous C. A review of key terminology and definitions used for birth defects globally. J Community Genet 2023;14:241-62.
3. El-Hattab AW, Almannai M, Sutton VR. Newborn screening: history, current status, and future directions. Pediatr Clin N Am 2018;65:389-405.
4. Howson CP, Cedergren B, Giugliani R, et al. Universal newborn screening: a roadmap for action. Mol Genet Metab 2018;124:177-83.
5. Maccready RA, Hussey MG. Newborn phenylketonuria detection program in massachusetts. Am J Public Health Nations Health 1964;54:2075-81.
6. Levy HL. Robert guthrie and the trials and tribulations of newborn screening. Int J Neonatal Screen 2021;7:5.
7. Caggana M, Jones EA, Shahied SI, Tanksley S, Hermerath CA, Lubin IM. Newborn screening: from guthrie to whole genome sequencing. Public Health Rep 2013;128:14-9.
8. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-43.
9. Parker SP, Cubitt WD. The use of the dried blood spot sample in epidemiological studies. J Clin Pathol 1999;52:633-9.
10. Population screening by guthrie test for phenylketonuria in South-East Scotland. Report by the consultant paediatricians and medical officers of health of the S.E. Scotland hospital region. Br Med J 1968;1:674-6.
11. Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr 1975;86:670-4.
12. Pang S, Hotchkiss J, Drash AL, Levine LS, New MI. Microfilter paper method for 17α-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1977;45:1003-8.
13. Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1979;1:472-4.
14. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 1993;39:66-71.
15. Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995;38:324-31.
16. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321-4.
17. Ellinwood NM. Newborn screening and the recommended uniform screening panel: optimal submissions and suggested improvements based on an advocacy organization’s decade-long experience. Am J Med Genet C Semin Med Genet 2022;190:156-61.
18. Therrell BL, Padilla CD, Loeber JG, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol 2015;39:171-87.
19. Advisory Committee on Heritable Disorders in Newborns and Children. Recommended uniform screening panel. 2018. Available from: https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp [Last accessed on 27 Feb 2024].
20. Padilla CD, de la Paz EM. Genetic services and testing in the Philippines. J Community Genet 2013;4:399-411.
21. Sustainable Development Goal. Goal 3: ensure healthy lives and promote wellbeing for all and at all ages. Available from: http://www.un.org/sustainabledevelopment/health/ [Last accessed on 27 Feb 2024].
22. Stats Sa. Statistical release P0302. Mid-year population estimates 2022. Available from: http://www.statssa.gov.za/publications/P0302/P03022022.pdf [Last accessed on 27 Feb 2024].
23. Stats Sa. Statistical release P0305. Recorded live births 2021. Available from: http://www.statssa.gov.za/publications/P0305/P03052021.pdf [Last accessed on 27 Feb 2024].
24. Dorrington R, Bradshaw D, Laubscher R, Nannan N. Rapid mortality surveillance report 2019 & 2020. Cape Town: South African Medical Research Council. 2021. Available from: https://www.samrc.ac.za/sites/default/files/attachments/2022-08/Rapid%20Mortality%20Surveillance%20Report%202019%262020.pdf [Last accessed on 27 Feb 2024].
25. Wessels J, Sherman G, Bamford L, et al. The updated South African national guideline for the prevention of mother to child transmission of communicable infections (2019). South Afr J HIV Med 2020;21:1079.
26. Stats Sa. Statistical release P0318. General household survey 2022. Available from: https://www.statssa.gov.za/publications/P0318/P03182022.pdf [Last accessed on 27 Feb 2024].
27. Pillay Y, Pienaar S, Barron P, Zondi T. Impact of COVID-19 on routine primary healthcare services in South Africa. S Afr Med J 2021;111:714-9.
28. Chuene TA, Kgarose MF. The readiness of public hospitals on the implementation of national health insurance in South Africa: a systematic review. Int J Soc Sci Res Rev 2023;6:153-66.
29. Pauw TL. Catching up with the constitution: an analysis of national health insurance in South Africa post-apartheid. Dev South Afr 2022;39:921-34.
30. Mukwena NV, Manyisa ZM. Factors influencing the preparedness for the implementation of the national health insurance scheme at a selected hospital in Gauteng province, South Africa. BMC Health Serv Res 2022;22:1006.
31. Murphy SD, Moosa S. The views of public service managers on the implementation of national health insurance in primary care: a case of Johannesburg health district, gauteng province, republic of South Africa. BMC Health Serv Res 2021;21:969.
32. Michel J, Tediosi F, Egger M, et al. Universal health coverage financing in South Africa: wishes vs reality. J Glob Health Rep 2020;4:e2020061.
33. National health insurance. Healthcare for all South Africans. Understanding national health insurance. Available from: https://www.hst.org.za/publications/NonHST%20Publications/Booklet%20-%20Understanding%20National%20Health%20Insurance.pdf [Last accessed on 27 Feb 2024].
34. Malherbe HL, Christianson AL, Aldous C. Need for services for the care and prevention of congenital disorders in South Africa as the country’s epidemiological transition evolves. S Afr Med J 2015;105:186-8.
35. Arnold C, Laura G, Hilary H, et al. Genetic testing in emerging economies (GenTEE). Summary report. Ispra, Italy: Publications Office of the European Union. 2013. Available from: https://op.europa.eu/en/publication-detail/-/publication/12497195-cbaf-4af1-b22f-8057e5b9b411 [Last accessed on 27 Feb 2024].
36. Malherbe HL, Christianson AL, Woods D, Aldous C. The case for the genetic nurse in South Africa. J Community Genet 2017;8:65-73.
37. Dorrington R, Bradshaw D, Laubscher R, Nannan N. Rapid mortality surveillance report 2018. Available from: https://www.samrc.ac.za/sites/default/files/attachments/2022-08/RapidMortalitySurveillanceReport2018.pdf [Last accessed on 27 Feb 2024].
38. Malherbe HL, Aldous C, Woods D, Christianson A. The contribution of congenital disorders to child mortality in South Africa. Durban: Health Systems Trust. 2016; pp. 137-52. Available from: https://www.hst.org.za/publications/South%20African%20Health%20Reviews/12%20The%20contribution%20of%20congenital%20disorders%20to%20child%20mortality%20in%20South%20Africa.pdf [Last accessed on 27 Feb 2024].
39. Kerber KJ, Lawn JE, Johnson LF, et al. South African child deaths 1990-2011: have HIV services reversed the trend enough to meet millennium development goal 4? AIDS 2013;27:2637-48.
40. Perin J, Mai CT, De Costa A, et al. Systematic estimates of the global, regional and national under-5 mortality burden attributable to birth defects in 2000-2019: a summary of findings from the 2020 WHO estimates. BMJ Open 2023;13:e067033.
42. Modell B, Kuliev A. The history of community genetics: the contribution of the haemoglobin disorders. Community Genet 1998;1:3-11.
43. Hitzeroth HW, Niehaus CE, Brill DC. Phenylketonuria in South Africa. A report on the status quo. S Afr Med J 1995;85:33-6.
45. Henderson HE, Goodman R, Schram J, Diamond E, Daneel A. Biochemical screening for inherited metabolic disorders in the mentally retarded. S Afr Med J 1981;60:731-3.
46. Hitzeroth H. Screening for congenital hypothyroidism in South Africa. Report on a national workshop (1992). S Afr Med J 1994;84:106-8. Available from: http://archive.samj.org.za/1994%20VOL%2084%20Jan-Dec/Articles/02%20February/1.17%20SCREENING%20FOR%20CONGENITAL%20HYPOTHYROIDISM%20IN%20SOUTH%20AFRICA%20-%20REPORT%20ON%20A%20NATIONAL%20WORKSHOP%201992.pdf [Last accessed on 29 Feb 2024]
48. Bernstein RE, Op’t Hof J, Hitzeroth HW. Neonatal screening for congenital hypothyroidism. A decade's review, including South Africa. S Afr Med J 1988;73:339-43.
49. Bernstein RE. Congenital hypothyroidism. Clinicopathological aspects and biochemical screening. S Afr Med J 1981;59:710-4.
50. Philotheou A, Bonnici F. Outcome for congenital hypothyroidism and early results of neonatal screening. In Paper presented at the 22nd Congress of the Society for Endocrinology, Metabolism and Diabetes of Southern Africa, Sun City, Bophutatswana, 20-23 March 1985.
51. Lloyd-Puryear M, Brower A, Berry SA, Brosco JP, Bowdish B, Watson MS. Foundation of the newborn screening translational research network and its tools for research. Genet Med 2019;21:1271-9.
52. Vorster BC. Presentation: national newborn screening programme to identify metabolism errors associated with mental retardation. IAEA-NECSA project SAF/6/004 & 006. Center for Human Metabolomics, Potchefstroom, South Africa: North-West University; 2016.
53. National Department of Health. Human genetics policy guidelines for the management and prevention of genetic disorders, birth defects and disabilities. Pretoria: National Department of Health. 2001. Available from: https://www.gov.za/sites/default/files/gcis_document/201409/humangenetics0.pdf [Last accessed on 27 Feb 2024].
54. Carrihill MM, Delport SV. An audit of the thyroid screening programme in the Peninsula Maternal and neonatal services (PMNS). J Endocrinol Metab Diabetes South Afr 2007;12:27. Available from: https://go.gale.com/ps/i.do?id=GALE%7CA168164786&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=16089677&p=AONE&sw=w&userGroupName=anon%7E3d63112e&aty=open-web-entry [Last accessed on 27 Feb 2024].
55. National Department of Health. Clinical guidelines for genetic services - 2021. Available from: https://knowledgehub.health.gov.za/elibrary/clinical-guidelines-genetics-services-2021 [Last accessed on 27 Feb 2024].
56. Allanson ER, Pattinson RC. Quality-of-care audits and perinatal mortality in South Africa. Bull World Health Organ 2015;93:424-8.
57. Horwood C, Haskins L, Phakathi S, McKerrow N. A health systems strengthening intervention to improve quality of care for sick and small newborn infants: results from an evaluation in district hospitals in KwaZulu-Natal, South Africa. BMC Pediatr 2019;19:29.
58. Niekerk AM, Cullis RM, Linley LL, Zühlke L. Feasibility of pulse oximetry pre-discharge screening implementation for detecting critical congenital heart lesions in newborns in a secondary level maternity hospital in the Western Cape, South Africa: the “POPSICLe” study. S Afr Med J 2016;106:817-21.
59. Bezuidenhout JK, Khoza-Shangase K, De Maayer T, Strehlau R. Outcomes of newborn hearing screening at an academic secondary level hospital in Johannesburg, South Africa. S Afr J Commun Disord 2021;68:e1-8.
60. Gina A, Bednarczuk NF, Jayawardena A, Rea P, Arshad Q, Saman Y. Universal newborn hearing screening in South Africa: a single-centre study. BMJ Paediatr Open 2021;5:e000976.
61. Kanji A. Newborn and infant hearing screening at primary healthcare clinics in South Africa designated as national health insurance pilot sites: an exploratory study. S Afr J Commun Disord 2022;69:e1-7.
62. Conradie EH, Malherbe H, Hendriksz CJ, Dercksen M, Vorster BC. An overview of benefits and challenges of rare disease biobanking in Africa, focusing on South Africa. Biopreserv Biobank 2021;19:143-50.
63. Dercksen M, Conradie EH, Hendriksz CJ, Malherbe H, Vorster BC. The advantages of rare disease biobanking: a localised source of genetic knowledge to benefit the South African rare disease community and related stakeholders worldwide. S Afr Med J 2023;113:1512-3. Available from: https://journals.co.za/doi/full/10.7196/SAMJ.2023.v113i12.1507 [Last accessed on 27 Feb 2024]
64. Spooner E, Govender K, Reddy T, et al. Point-of-care HIV testing best practice for early infant diagnosis: an implementation study. BMC Public Health 2019;19:731.
65. Christianson A, Zimmern R, Kristoffersson U, et al. Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations. J Community Genet 2013;4:297-308.
